Vitreo-retinal traction and anastrozole use
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://link.springer.com/content/pdf/10.1007/s10549-008-0156-5.pdf
Reference36 articles.
1. Conte P, Frassoldati A (2007) Aromatase inhibitors in the adjuvant treatment of postmenopausal women with early breast cancer: Putting safety issues into perspective. Breast J 13:28–35. doi: 10.1111/j.1524-4741.2006.00359.x
2. Buzdar AU, Coombes RC, Goss PE et al (2008) Summary of aromatase inhibitor clinical trials in postmenopausal women with early breast cancer. Cancer 112:700–709. doi: 10.1002/cncr.23193
3. Partridge AH, LaFountain A, Mayer E et al (2008) Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer. J Clin Oncol 26:556–562. doi: 10.1200/JCO.2007.11.5451
4. Howell A, Cuzick J, Baum M et al (2005) Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years’ adjuvant treatment for breast cancer. Lancet 365:60–62. doi: 10.1016/S0140-6736(05)74803-0
5. Garreau JR, Delamelena T, Walts D et al (2006) Side effects of aromatase inhibitors versus tamoxifen: the patients’ perspective. Am J Surg 192:496–498. doi: 10.1016/j.amjsurg.2006.06.018
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Epiretinal membrane formation associated with letrozole therapy – Two case reports;Indian Journal of Ophthalmology - Case Reports;2024-01
2. Risk of ocular adverse events with aromatase inhibitors;Canadian Journal of Ophthalmology;2023-11
3. A case report of cystoid macular edema, uveitis and vitreomacular traction in a patient taking Anastrozole;American Journal of Ophthalmology Case Reports;2022-03
4. Retinal toxicities of systemic anticancer drugs;Survey of Ophthalmology;2022-01
5. Ocular Side Effects of Aromatase Inhibitor Endocrine Therapy in Breast Cancer – A Review;In Vivo;2021-12-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3